Imiquimod-induced vitiligo.
Al-Dujaili
Zeena
Z
Tulane Medical School, New Orleans, Louisiana, USA.
Hsu
Sylvia
S
D000287:Administration, Topical; D000328:Adult; D000634:Aminoquinolines / Q000009:adverse effects* / Q000627:therapeutic use; D003218:Condylomata Acuminata / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D005832:Genital Diseases, Male / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D000077271:Imiquimod; D008297:Male; D018570:Risk Assessment; D014820:Vitiligo / Q000139:chemically induced* / Q000503:physiopathology
D000634:Aminoquinolines; D000077271:Imiquimod